JP2022537581A5 - - Google Patents
Info
- Publication number
- JP2022537581A5 JP2022537581A5 JP2021576065A JP2021576065A JP2022537581A5 JP 2022537581 A5 JP2022537581 A5 JP 2022537581A5 JP 2021576065 A JP2021576065 A JP 2021576065A JP 2021576065 A JP2021576065 A JP 2021576065A JP 2022537581 A5 JP2022537581 A5 JP 2022537581A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962864988P | 2019-06-21 | 2019-06-21 | |
| US62/864,988 | 2019-06-21 | ||
| US201962871356P | 2019-07-08 | 2019-07-08 | |
| US62/871,356 | 2019-07-08 | ||
| PCT/US2020/038703 WO2020257631A2 (en) | 2019-06-21 | 2020-06-19 | Ppm1a inhibitors and methods of using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537581A JP2022537581A (ja) | 2022-08-26 |
| JP2022537581A5 true JP2022537581A5 (https=) | 2023-06-26 |
| JPWO2020257631A5 JPWO2020257631A5 (https=) | 2023-06-26 |
Family
ID=74040507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576065A Withdrawn JP2022537581A (ja) | 2019-06-21 | 2020-06-19 | Ｐｐｍ１阻害剤およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220372489A1 (https=) |
| EP (1) | EP3987030A4 (https=) |
| JP (1) | JP2022537581A (https=) |
| KR (1) | KR20220035137A (https=) |
| CN (1) | CN114729355A (https=) |
| AU (1) | AU2020296104A1 (https=) |
| CA (1) | CA3144063A1 (https=) |
| IL (1) | IL289127A (https=) |
| WO (1) | WO2020257631A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4392562A4 (en) * | 2021-08-27 | 2025-09-24 | Ionis Pharmaceuticals Inc | COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION |
| WO2023102188A1 (en) * | 2021-12-03 | 2023-06-08 | Quralis Corporation | Gapmer antisense oligonucleotides with modified backbone chemistries |
| KR102856378B1 (ko) * | 2022-09-30 | 2025-09-08 | 주식회사 젬백스앤카엘 | 4r 타우병증의 치료 또는 예방용 펩티드 |
| KR102775989B1 (ko) * | 2022-11-01 | 2025-03-04 | 윤주호 | 콜치신과 메트포르민을 유효성분으로 하는 퇴행성 신경계 질환의 예방 또는 치료용 조성물 |
| CN117031014A (zh) * | 2023-08-14 | 2023-11-10 | 陕西脉元生物科技有限公司 | 抗matr3自身抗体的试剂在制备检测神经系统自身免疫疾病的产品中的应用及试剂盒 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2227306A1 (en) * | 1995-09-01 | 1997-03-27 | Ramot-University Authority For Applied Research And Industrial Developme Nt Ltd. | Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection |
| JPH11512294A (ja) * | 1995-09-01 | 1999-10-26 | ラモット ユニヴァーシティー オーソリティ フォア アップライド リサーチ アンド インダストリアル ディヴェロプメント リミテッド | 癌の治療、予防および発見を目的とする腫瘍細胞での蛋白ホスファターゼ２Ｃ−ＰＰ２Ｃα−発現の操作と検出 |
| US20030050270A1 (en) * | 1998-11-20 | 2003-03-13 | Monia Brett P. | Antisense modulation of Inhibitor-kappa B Kinase-beta expression |
| WO2003014321A2 (en) * | 2001-08-10 | 2003-02-20 | The Rockefeller University | Compositions and methods for modulation of darpp-32 phosphorylation |
| GB0207251D0 (en) * | 2002-03-27 | 2002-05-08 | Isis Innovation | Lymphoma-associated antigens |
| US20040102397A1 (en) * | 2002-11-22 | 2004-05-27 | Isis Pharmaceuticals Inc. | Modulation of PPM1B expression |
| AU2003270900A1 (en) * | 2002-09-25 | 2004-04-19 | Pharmacia Corporation | Antisense modulation of microsomal prostaglandin e2 synthase expression |
| AU2003271651A1 (en) * | 2002-10-04 | 2004-04-23 | Bayer Healthcare Ag | Regulation of human pp2c-like protein phosphatase |
| WO2011073903A1 (en) * | 2009-12-14 | 2011-06-23 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
| US20140200261A1 (en) * | 2013-01-17 | 2014-07-17 | Moderna Therapeutics, Inc. | Signal-sensor polynucleotides for the alteration of cellular phenotypes |
| US11096956B2 (en) * | 2015-12-14 | 2021-08-24 | Stoke Therapeutics, Inc. | Antisense oligomers and uses thereof |
-
2020
- 2020-06-19 US US17/621,320 patent/US20220372489A1/en active Pending
- 2020-06-19 CN CN202080057853.2A patent/CN114729355A/zh active Pending
- 2020-06-19 EP EP20825513.3A patent/EP3987030A4/en not_active Withdrawn
- 2020-06-19 CA CA3144063A patent/CA3144063A1/en active Pending
- 2020-06-19 WO PCT/US2020/038703 patent/WO2020257631A2/en not_active Ceased
- 2020-06-19 JP JP2021576065A patent/JP2022537581A/ja not_active Withdrawn
- 2020-06-19 KR KR1020227002134A patent/KR20220035137A/ko not_active Withdrawn
- 2020-06-19 AU AU2020296104A patent/AU2020296104A1/en not_active Abandoned
-
2021
- 2021-12-19 IL IL289127A patent/IL289127A/en unknown